• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调强放射治疗在预防鼻咽癌晚期耳部并发症方面是否优于传统技术?

Is intensity-modulated radiotherapy superior to conventional techniques to prevent late ear complications of nasopharyngeal cancer?

作者信息

Ant Ayca, Yazici Ömer, Atabey Pinar, Aslan Ferit Ferhat, Duran Arzubetul, Ozlugedik Samet, Kemaloglu Yusuf Kemal

机构信息

Department of Otorhinolaryngology, Head and Neck Surgery, University of Medical Sciences, Ankara A.Y. Oncology Education and Research Hospital, Yenimahalle, 06200, Ankara, Turkey.

Department of Radiation Oncology, University of Medical Sciences, Ankara A.Y. Oncology Education and Research Hospital, Ankara, Turkey.

出版信息

Eur Arch Otorhinolaryngol. 2019 Apr;276(4):977-984. doi: 10.1007/s00405-019-05299-7. Epub 2019 Jan 22.

DOI:10.1007/s00405-019-05299-7
PMID:30671602
Abstract

PURPOSE

This study analyzed the late ear complications of radiotherapy for nasopharyngeal cancer (NPC) and compared the conventional and intensity-modulated radiotherapy (2D-RT and IMRT, respectively).

METHODS

At 2-21 years after the end of NPC treatment, 104 ears of 52 patients were evaluated with the otoscopic examination, pure tone audiometry test, tympanometry, and subjective complaints by being blinded to the radiotherapy technique.

RESULTS

There were no differences in terms of the pathology of the external, middle or inner ear, air and bone-conduction hearing thresholds, and the air-bone (A-B) gap at 500, 1000, 2000, and 4000 Hz, and tympanometry types between 2D-RT and IMRT groups (p > 0.05). There were positive correlations between the values of A500 and A1000 thresholds; gap 500, 4000, and mean cochlear RT dose (p < 0.05). There were positive correlations between the values of A500, A1000, and A4000 thresholds; gap 500, 1000, 2000, 4000, and maximum cochlear RT dose (p < 0.05).

CONCLUSION

IMRT was not found to be superior to 2D-RT to prevent RT-induced ear complications. The solution of the middle ear problems must be the goal of the strategies for complications treatment.

摘要

目的

本研究分析了鼻咽癌(NPC)放疗后的晚期耳部并发症,并比较了传统放疗和调强放疗(分别为2D-RT和IMRT)。

方法

在NPC治疗结束后2至21年,对52例患者的104只耳朵进行了耳镜检查、纯音听力测试、鼓室图检查,并在不了解放疗技术的情况下收集主观症状。

结果

2D-RT组和IMRT组在外耳、中耳或内耳的病理、气导和骨导听力阈值、500、1000、2000和4000Hz的气骨(A-B)间隙以及鼓室图类型方面均无差异(p>0.05)。A500和A1000阈值的值与500、4000间隙以及平均耳蜗放疗剂量之间存在正相关(p<0.05)。A500、A1000和A4000阈值的值与500、1000、2000、4000间隙以及最大耳蜗放疗剂量之间存在正相关(p<0.05)。

结论

未发现IMRT在预防放疗引起的耳部并发症方面优于2D-RT。解决中耳问题必须是并发症治疗策略的目标。

相似文献

1
Is intensity-modulated radiotherapy superior to conventional techniques to prevent late ear complications of nasopharyngeal cancer?调强放射治疗在预防鼻咽癌晚期耳部并发症方面是否优于传统技术?
Eur Arch Otorhinolaryngol. 2019 Apr;276(4):977-984. doi: 10.1007/s00405-019-05299-7. Epub 2019 Jan 22.
2
Evolution of postirradiated sudden deafness in nasopharyngeal carcinoma survivors during the past two decades.过去二十年鼻咽癌幸存者放疗后突发性耳聋的演变
Laryngoscope. 2016 Sep;126(9):2016-21. doi: 10.1002/lary.25893. Epub 2016 Feb 10.
3
Long-term hearing results and otological complications of nasopharyngeal carcinoma patients: comparison between treatment with conventional two-dimensional radiotherapy and intensity-modulated radiotherapy.鼻咽癌患者的长期听力结果及耳科并发症:传统二维放疗与调强放疗的疗效比较
ORL J Otorhinolaryngol Relat Spec. 2012;74(4):228-33. doi: 10.1159/000341096. Epub 2012 Aug 17.
4
Irradiated ears in nasopharyngeal carcinoma survivors: A review.鼻咽癌幸存者的耳部放疗:综述
Laryngoscope. 2019 Mar;129(3):637-642. doi: 10.1002/lary.27303. Epub 2018 Sep 8.
5
Postirradiation otitis media with effusion in nasopharyngeal carcinoma patients treated by intensity-modulated radiotherapy.调强放疗后分泌性中耳炎在鼻咽癌患者中的发病情况。
Laryngoscope. 2013 Sep;123(9):2148-53. doi: 10.1002/lary.23215. Epub 2013 Jul 8.
6
Hearing Assessment after Treatment of Nasopharyngeal Carcinoma with CRT and IMRT Techniques.采用同步放化疗(CRT)和调强放射治疗(IMRT)技术治疗鼻咽癌后的听力评估
Biomed Res Int. 2015;2015:769806. doi: 10.1155/2015/769806. Epub 2015 Aug 16.
7
Dosimetric parameters associated with conductive or sensorineural hearing loss 5 years after intensity-modulated radiation therapy in nasopharyngeal carcinoma.鼻咽癌调强放射治疗5年后与传导性或感音神经性听力损失相关的剂量学参数。
Acta Otolaryngol. 2019 Mar;139(3):263-268. doi: 10.1080/00016489.2019.1566778. Epub 2019 Mar 14.
8
A study of middle ear function in the treatment of nasopharyngeal carcinoma with IMRT technique.调强适形放疗技术治疗鼻咽癌中耳功能的研究。
Radiother Oncol. 2009 Dec;93(3):530-3. doi: 10.1016/j.radonc.2009.09.013. Epub 2009 Oct 21.
9
Long-term hearing status after radiotherapy for nasopharyngeal carcinoma.鼻咽癌放疗后的长期听力状况。
Auris Nasus Larynx. 1998 Jan;25(1):21-4. doi: 10.1016/s0385-8146(97)10009-8.
10
Sensorineural Hearing Loss in Nasopharyngeal Carcinoma Survivors in the Modern Treatment Era - The Early and Late Effects of Radiation and Cisplatin.现代治疗时代鼻咽癌幸存者的感音神经性听力损失——放疗和顺铂的早期及晚期影响
Clin Oncol (R Coll Radiol). 2022 Apr;34(4):e160-e167. doi: 10.1016/j.clon.2021.10.013. Epub 2021 Nov 10.

本文引用的文献

1
Hearing Assessment after Treatment of Nasopharyngeal Carcinoma with CRT and IMRT Techniques.采用同步放化疗(CRT)和调强放射治疗(IMRT)技术治疗鼻咽癌后的听力评估
Biomed Res Int. 2015;2015:769806. doi: 10.1155/2015/769806. Epub 2015 Aug 16.
2
Dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma.鼻咽癌调强放疗后耳部疾病相关的剂量体积因素
Sci Rep. 2015 Sep 1;5:13525. doi: 10.1038/srep13525.
3
Late toxicities after intensity-modulated radiotherapy for nasopharyngeal carcinoma: patient and treatment-related risk factors.
调强放疗治疗鼻咽癌后的晚期毒性:患者和治疗相关的危险因素。
Br J Cancer. 2014 Jan 7;110(1):49-54. doi: 10.1038/bjc.2013.720. Epub 2013 Nov 19.
4
Characteristics of radiation-induced sensorineural hearing loss in head and neck cancer: a systematic review.头颈部癌症放射性感音神经性听力损失的特征:系统评价。
Head Neck. 2013 Nov;35(11):1662-8. doi: 10.1002/hed.23201. Epub 2012 Dec 22.
5
Organ-sparing radiation therapy for head and neck cancer.头颈部癌症的保器官放射治疗。
Nat Rev Clin Oncol. 2011 Jul 26;8(11):639-48. doi: 10.1038/nrclinonc.2011.106.
6
Comparison of otologic complications between intensity-modulated and two-dimensional radiotherapies in nasopharyngeal carcinoma patients.比较鼻咽癌患者调强放疗和二维放疗的耳科并发症。
Otolaryngol Head Neck Surg. 2010 Nov;143(5):662-8. doi: 10.1016/j.otohns.2010.07.012.
7
Long-term result of management of otitis media with effusion in patients with post-irradiated nasopharyngeal carcinoma.放疗后鼻咽癌患者中耳积液的长期治疗效果
Eur Arch Otorhinolaryngol. 2011 Feb;268(2):213-7. doi: 10.1007/s00405-010-1381-1. Epub 2010 Sep 15.
8
[Tolerance of normal tissues to radiation therapy: ear].[正常组织对放射治疗的耐受性:耳部]
Cancer Radiother. 2010 Jul;14(4-5):284-9. doi: 10.1016/j.canrad.2010.02.011. Epub 2010 Jun 4.
9
Incidence of long-term ipsilateral and contralateral ototoxicity following radiotherapy for nasopharyngeal carcinoma.鼻咽癌放疗后长期同侧和对侧耳毒性的发生率。
Auris Nasus Larynx. 2011 Feb;38(1):95-100. doi: 10.1016/j.anl.2010.03.012. Epub 2010 Jun 11.
10
Prospective study of sensorineural hearing loss following radiotherapy for nasopharyngeal carcinoma.鼻咽癌放疗后感音神经性听力损失的前瞻性研究。
J Laryngol Otol. 2010 Jan;124(1):32-6. doi: 10.1017/S0022215109991435. Epub 2009 Oct 20.